Sign In
Get Clay Free →

Suggestions

    Tracey Mullen

    Chief Executive Officer at Abveris

    Tracey Mullen is an accomplished professional with a strong background in the biotechnology industry, particularly in antibody discovery and drug development.

    She holds an EMBA from Quantic School of Business and Technology, showcasing her commitment to continuous learning and professional growth. Additionally, she completed a Bachelor of Science in Chemical-Biological Engineering from the prestigious Massachusetts Institute of Technology (MIT).

    Tracey has held significant leadership positions throughout her career, currently serving as the Chief Executive Officer at Abveris. Her previous roles include Chief Operating Officer, Director of Antibody Discovery Operations, and other key positions at Abveris, illustrating her extensive experience within the organization.

    Prior to her time at Abveris, Tracey gained valuable experience working in various research and development roles at top biotech companies and academic institutions. She was involved in antibody discovery and development at Biogen and Abpro, and contributed as a Research Associate at Beth Israel Deaconess Medical Center. Her early career includes serving as an Undergraduate Researcher at MIT, where she laid the foundation for her future success.

    With a strong educational background, hands-on experience in antibody discovery operations, and a track record of leadership in the biotechnology sector, Tracey Mullen continues to make a significant impact in her field.

    Keywords: Biotechnology, Antibody Discovery, Drug Development, Leadership, Biotech Industry

    Tracey Mullen
    Add to my network

    Location

    Boston, Massachusetts, United States